GlassScriptPhysician profile
Colin Beacom
NPI 1700427796
$1,467.04
in general payments reported to CMS, 2019-2025
25 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $770 · 2022: $331 · 2023: $199 · 2024: $31.92 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $465.35 | 2022-2025 | |
| Astellas Pharma US INC | $116.01 | 2021 | |
| Ethicon US, LLC | $89.18 | 2023 | Surgicel Nu-Knit, Echelon Flex, Stratafix |
| Tolmar Pharmaceuticals, INC. | $89.02 | 2021 | |
| Myriad Genetic Laboratories, INC. | $75.09 | 2021 | |
| Innovation Technologies INC | $74.65 | 2023 | Irrisept |
| Janssen Biotech, INC. | $65.77 | 2021 | |
| Coloplast Corp | $54.37 | 2021 | |
| Endo Pharmaceuticals INC. | $47.12 | 2021 | |
| Dendreon Pharmaceuticals LLC | $46.47 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $35.67 | 2021 | |
| Kci USA, INC. | $35.60 | 2023 | V.A.C. Veraflo, Prevena, Snap |
| Conmed Corporation | $31.92 | 2024 | Airseal |
| Bayer Healthcare Pharmaceuticals INC. | $30.30 | 2021 | |
| Urovant Sciences INC | $23.75 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $23.61 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.55 | 2021 | |
| Ambu INC. | $22.40 | 2021 | |
| Merck Sharp & Dohme LLC | $21.26 | 2021 | |
| Travere Therapeutics, INC. | $18.48 | 2021 | |
| Urogen Pharma, INC. | $17.82 | 2021 | |
| Myovant Sciences INC. | $17.77 | 2021 | |
| Allergan, INC. | $16.23 | 2021 | |
| Amgen INC. | $14.49 | 2021 | |
| Therapeuticsmd, INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Beacom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.